Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Lipids Health Dis ; 23(1): 37, 2024 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-38308271

RESUMO

BACKGROUND: Interstitial fibrosis and tubular atrophy (IF/TA), a histologic feature of kidney allograft destruction, is linked to decreased allograft survival. The role of lipid metabolism is well-acknowledged in the area of chronic kidney diseases; however, its role in kidney allograft fibrosis is still unclarified. In this study, how lipid metabolism contributes to kidney allografts fibrosis was examined. METHODS: A comprehensive bioinformatic comparison between IF/TA and normal kidney allograft in the Gene Expression Omnibus (GEO) database was conducted. Further validations through transcriptome profiling or pathological staining of human recipient biopsy samples and in rat models of kidney transplantation were performed. Additionally, the effects of enhanced lipid metabolism on changes in the fibrotic phenotype induced by TGF-ß1 were examined in HK-2 cell. RESULTS: In-depth analysis of the GEO dataset revealed a notable downregulation of lipid metabolism pathways in human kidney allografts with IF/TA. This decrease was associated with increased level of allograft rejection, inflammatory responses, and epithelial mesenchymal transition (EMT). Pathway enrichment analysis showed the downregulation in mitochondrial LC-fatty acid beta-oxidation, fatty acid beta-oxidation (FAO), and fatty acid biosynthesis. Dysregulated fatty acid metabolism was also observed in biopsy samples from human kidney transplants and in fibrotic rat kidney allografts. Notably, the areas affected by IF/TA had increased immune cell infiltration, during which increased EMT biomarkers and reduced CPT1A expression, a key FAO enzyme, were shown by immunohistochemistry. Moreover, under TGF-ß1 induction, activating CPT1A with the compound C75 effectively inhibited migration and EMT process in HK-2 cells. CONCLUSIONS: This study reveal a critical correlation between dysregulated lipid metabolism and kidney allograft fibrosis. Enhancing lipid metabolism with CPT1A agonists could be a therapeutic approach to mitigate kidney allografts fibrosis.


Assuntos
Metabolismo dos Lipídeos , Fator de Crescimento Transformador beta1 , Humanos , Ratos , Animais , Fator de Crescimento Transformador beta1/genética , Fator de Crescimento Transformador beta1/metabolismo , Metabolismo dos Lipídeos/genética , Rim/metabolismo , Fibrose , Aloenxertos/metabolismo , Aloenxertos/patologia , Ácidos Graxos/metabolismo
2.
Int J Mol Sci ; 15(3): 4915-37, 2014 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-24651462

RESUMO

Nuclear receptors (NRs) are closely associated with various major diseases such as cancer, diabetes, inflammatory disease, and osteoporosis. Therefore, NRs have become a frequent target for drug development. During the process of developing drugs against these diseases by targeting NRs, we are often facing a problem: Given a NR and chemical compound, can we identify whether they are really in interaction with each other in a cell? To address this problem, a predictor called "iNR-Drug" was developed. In the predictor, the drug compound concerned was formulated by a 256-D (dimensional) vector derived from its molecular fingerprint, and the NR by a 500-D vector formed by incorporating its sequential evolution information and physicochemical features into the general form of pseudo amino acid composition, and the prediction engine was operated by the SVM (support vector machine) algorithm. Compared with the existing prediction methods in this area, iNR-Drug not only can yield a higher success rate, but is also featured by a user-friendly web-server established at http://www.jci-bioinfo.cn/iNR-Drug/, which is particularly useful for most experimental scientists to obtain their desired data in a timely manner. It is anticipated that the iNR-Drug server may become a useful high throughput tool for both basic research and drug development, and that the current approach may be easily extended to study the interactions of drug with other targets as well.


Assuntos
Algoritmos , Desenho Assistido por Computador , Desenho de Fármacos , Preparações Farmacêuticas/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Ligação Competitiva , Biologia Computacional/métodos , Humanos , Preparações Farmacêuticas/administração & dosagem , Preparações Farmacêuticas/química , Receptores Citoplasmáticos e Nucleares/antagonistas & inibidores , Receptores Citoplasmáticos e Nucleares/química , Reprodutibilidade dos Testes , Transdução de Sinais/efeitos dos fármacos , Máquina de Vetores de Suporte
3.
J Theor Biol ; 337: 71-9, 2013 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-23988798

RESUMO

Many crucial functions in life, such as heartbeat, sensory transduction and central nervous system response, are controlled by cell signalings via various ion channels. Therefore, ion channels have become an excellent drug target, and study of ion channel-drug interaction networks is an important topic for drug development. However, it is both time-consuming and costly to determine whether a drug and a protein ion channel are interacting with each other in a cellular network by means of experimental techniques. Although some computational methods were developed in this regard based on the knowledge of the 3D (three-dimensional) structure of protein, unfortunately their usage is quite limited because the 3D structures for most protein ion channels are still unknown. With the avalanche of protein sequences generated in the post-genomic age, it is highly desirable to develop the sequence-based computational method to address this problem. To take up the challenge, we developed a new predictor called iCDI-PseFpt, in which the protein ion-channel sample is formulated by the PseAAC (pseudo amino acid composition) generated with the gray model theory, the drug compound by the 2D molecular fingerprint, and the operation engine is the fuzzy K-nearest neighbor algorithm. The overall success rate achieved by iCDI-PseFpt via the jackknife cross-validation was 87.27%, which is remarkably higher than that by any of the existing predictors in this area. As a user-friendly web-server, iCDI-PseFpt is freely accessible to the public at the website http://www.jci-bioinfo.cn/iCDI-PseFpt/. Furthermore, for the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated math equations presented in the paper just for its integrity. It has not escaped our notice that the current approach can also be used to study other drug-target interaction networks.


Assuntos
Algoritmos , Aminoácidos/metabolismo , Células/metabolismo , Canais Iônicos/metabolismo , Preparações Farmacêuticas/metabolismo , Humanos , Internet , Espectroscopia de Ressonância Magnética , Estrutura Secundária de Proteína , Reprodutibilidade dos Testes
4.
Cogn Neurodyn ; 12(4): 431-440, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30137879

RESUMO

Driver fatigue is increasingly a contributing factor for traffic accidents, so an effective method to automatically detect driver fatigue is urgently needed. In this study, in order to catch the main characteristics of the EEG signals, four types of entropies (based on the EEG signal of a single channel) were calculated as the feature sets, including sample entropy, fuzzy entropy, approximate entropy and spectral entropy. All feature sets were used as the input of a gradient boosting decision tree (GBDT), a fast and highly accurate boosting ensemble method. The output of GBDT determined whether a driver was in a fatigue state or not based on their EEG signals. Three state-of-the-art classifiers, k-nearest neighbor, support vector machine and neural network were also employed. To assess our method, several experiments including parameter setting and classification performance comparison were performed on 22 subjects. The results indicated that it is possible to use only one EEG channel to detect a driver fatigue state. The average highest recognition rate in this work was up to 94.0%, which could meet the needs of daily applications. Our GBDT-based method may assist in the detection of driver fatigue.

5.
Healthc Technol Lett ; 5(2): 54-58, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29750113

RESUMO

Eye-tracking is an important approach to collect evidence regarding some participants' driving fatigue. In this contribution, the authors present a non-intrusive system for evaluating driver fatigue by tracking eye movement behaviours. A real-time eye-tracker was used to monitor participants' eye state for collecting eye-movement data. These data are useful to get insights into assessing participants' fatigue state during monotonous driving. Ten healthy subjects performed continuous simulated driving for 1-2 h with eye state monitoring on a driving simulator in this study, and these measured features of the fixation time and the pupil area were recorded via using eye movement tracking device. For achieving a good cost-performance ratio and fast computation time, the fuzzy K-nearest neighbour was employed to evaluate and analyse the influence of different participants on the variations in the fixation duration and pupil area of drivers. The findings of this study indicated that there are significant differences in domain value distribution of the pupil area under the condition with normal and fatigue driving state. Result also suggests that the recognition accuracy by jackknife validation reaches to about 89% in average, implying that show a significant potential of real-time applicability of the proposed approach and is capable of detecting driver fatigue.

6.
PLoS One ; 12(12): e0188756, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29220351

RESUMO

Driver fatigue is an important contributor to road accidents, and fatigue detection has major implications for transportation safety. The aim of this research is to analyze the multiple entropy fusion method and evaluate several channel regions to effectively detect a driver's fatigue state based on electroencephalogram (EEG) records. First, we fused multiple entropies, i.e., spectral entropy, approximate entropy, sample entropy and fuzzy entropy, as features compared with autoregressive (AR) modeling by four classifiers. Second, we captured four significant channel regions according to weight-based electrodes via a simplified channel selection method. Finally, the evaluation model for detecting driver fatigue was established with four classifiers based on the EEG data from four channel regions. Twelve healthy subjects performed continuous simulated driving for 1-2 hours with EEG monitoring on a static simulator. The leave-one-out cross-validation approach obtained an accuracy of 98.3%, a sensitivity of 98.3% and a specificity of 98.2%. The experimental results verified the effectiveness of the proposed method, indicating that the multiple entropy fusion features are significant factors for inferring the fatigue state of a driver.


Assuntos
Condução de Veículo , Eletroencefalografia/métodos , Fadiga/diagnóstico , Acidentes de Trânsito , Adolescente , Adulto , Fadiga/fisiopatologia , Humanos , Masculino , Adulto Jovem
7.
J Biomol Struct Dyn ; 33(10): 2221-33, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25513722

RESUMO

Information about the interactions of drug compounds with proteins in cellular networking is very important for drug development. Unfortunately, all the existing predictors for identifying drug-protein interactions were trained by a skewed benchmark data-set where the number of non-interactive drug-protein pairs is overwhelmingly larger than that of the interactive ones. Using this kind of highly unbalanced benchmark data-set to train predictors would lead to the outcome that many interactive drug-protein pairs might be mispredicted as non-interactive. Since the minority interactive pairs often contain the most important information for drug design, it is necessary to minimize this kind of misprediction. In this study, we adopted the neighborhood cleaning rule and synthetic minority over-sampling technique to treat the skewed benchmark datasets and balance the positive and negative subsets. The new benchmark datasets thus obtained are called the optimized benchmark datasets, based on which a new predictor called iDrug-Target was developed that contains four sub-predictors: iDrug-GPCR, iDrug-Chl, iDrug-Ezy, and iDrug-NR, specialized for identifying the interactions of drug compounds with GPCRs (G-protein-coupled receptors), ion channels, enzymes, and NR (nuclear receptors), respectively. Rigorous cross-validations on a set of experiment-confirmed datasets have indicated that these new predictors remarkably outperformed the existing ones for the same purpose. To maximize users' convenience, a public accessible Web server for iDrug-Target has been established at http://www.jci-bioinfo.cn/iDrug-Target/ , by which users can easily get their desired results. It has not escaped our notice that the aforementioned strategy can be widely used in many other areas as well.


Assuntos
Drogas em Investigação/química , Enzimas/química , Canais Iônicos/química , Receptores Citoplasmáticos e Nucleares/química , Receptores Acoplados a Proteínas G/química , Software , Benchmarking , Bases de Dados de Compostos Químicos , Conjuntos de Dados como Assunto , Desenho de Fármacos , Descoberta de Drogas , Drogas em Investigação/síntese química , Enzimas/metabolismo , Humanos , Internet , Canais Iônicos/metabolismo , Terapia de Alvo Molecular/métodos , Ligação Proteica , Curva ROC , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores Acoplados a Proteínas G/metabolismo
8.
PLoS One ; 8(8): e72234, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24015221

RESUMO

Involved in many diseases such as cancer, diabetes, neurodegenerative, inflammatory and respiratory disorders, G-protein-coupled receptors (GPCRs) are among the most frequent targets of therapeutic drugs. It is time-consuming and expensive to determine whether a drug and a GPCR are to interact with each other in a cellular network purely by means of experimental techniques. Although some computational methods were developed in this regard based on the knowledge of the 3D (dimensional) structure of protein, unfortunately their usage is quite limited because the 3D structures for most GPCRs are still unknown. To overcome the situation, a sequence-based classifier, called "iGPCR-drug", was developed to predict the interactions between GPCRs and drugs in cellular networking. In the predictor, the drug compound is formulated by a 2D (dimensional) fingerprint via a 256D vector, GPCR by the PseAAC (pseudo amino acid composition) generated with the grey model theory, and the prediction engine is operated by the fuzzy K-nearest neighbour algorithm. Moreover, a user-friendly web-server for iGPCR-drug was established at http://www.jci-bioinfo.cn/iGPCR-Drug/. For the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated math equations presented in this paper just for its integrity. The overall success rate achieved by iGPCR-drug via the jackknife test was 85.5%, which is remarkably higher than the rate by the existing peer method developed in 2010 although no web server was ever established for it. It is anticipated that iGPCR-Drug may become a useful high throughput tool for both basic research and drug development, and that the approach presented here can also be extended to study other drug - target interaction networks.


Assuntos
Descoberta de Drogas/métodos , Receptores Acoplados a Proteínas G/química , Software , Algoritmos , Sequência de Aminoácidos , Aminoácidos/química , Simulação por Computador , Humanos , Internet , Modelos Moleculares , Ligação Proteica , Receptores Acoplados a Proteínas G/antagonistas & inibidores
9.
Biomed Res Int ; 2013: 701317, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24371828

RESUMO

With the features of extremely high selectivity and efficiency in catalyzing almost all the chemical reactions in cells, enzymes play vitally important roles for the life of an organism and hence have become frequent targets for drug design. An essential step in developing drugs by targeting enzymes is to identify drug-enzyme interactions in cells. It is both time-consuming and costly to do this purely by means of experimental techniques alone. Although some computational methods were developed in this regard based on the knowledge of the three-dimensional structure of enzyme, unfortunately their usage is quite limited because three-dimensional structures of many enzymes are still unknown. Here, we reported a sequence-based predictor, called "iEzy-Drug," in which each drug compound was formulated by a molecular fingerprint with 258 feature components, each enzyme by the Chou's pseudo amino acid composition generated via incorporating sequential evolution information and physicochemical features derived from its sequence, and the prediction engine was operated by the fuzzy K-nearest neighbor algorithm. The overall success rate achieved by iEzy-Drug via rigorous cross-validations was about 91%. Moreover, to maximize the convenience for the majority of experimental scientists, a user-friendly web server was established, by which users can easily obtain their desired results.


Assuntos
Sequência de Aminoácidos , Aminoácidos/química , Internet , Algoritmos , Biologia Computacional , Bases de Dados de Proteínas
10.
Curr Top Med Chem ; 13(14): 1707-12, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23889048

RESUMO

Involved with many diseases such as cancer, diabetes, neurodegenerative, inflammatory and respiratory disorders, GPCRs (G-protein-coupled receptors) are the most frequent targets for drug development: over 50% of all prescription drugs currently on the market are actually acting by targeting GPCRs directly or indirectly. Found in every living thing and nearly all cells, ion channels play crucial roles for many vital functions in life, such as heartbeat, sensory transduction, and central nervous system response. Their dysfunction may have significant impact to human health, and hence ion channels are deemed as "the next GPCRs". To develop GPCR-targeting or ion-channel-targeting drugs, the first important step is to identify the interactions between potential drug compounds with the two kinds of protein receptors in the cellular networking. In this minireview, we are to introduce two predictors. One is called iGPCR-Drug accessible at http://www.jci-bioinfo.cn/iGPCR-Drug/; the other called iCDI-PseFpt at http://www.jci-bioinfo.cn/iCDI-PseFpt. The former is for identifying the interactions of drug compounds with GPCRs; while the latter for that with ion channels. In both predictors, the drug compound was formulated by the two-dimensional molecular fingerprint, and the protein receptor by the pseudo amino acid composition generated with the grey model theory, while the operation engine was the fuzzy K-nearest neighbor algorithm. For the convenience of most experimental pharmaceutical and medical scientists, a step-bystep guide is provided on how to use each of the two web-servers to get the desired results without the need to follow the complicated mathematics involved originally for their establishment.


Assuntos
Comunicação Celular , Desenho de Fármacos , Preparações Farmacêuticas/química , Receptores Acoplados a Proteínas G/antagonistas & inibidores , Receptores Acoplados a Proteínas G/química , Biologia Computacional , Humanos , Modelos Moleculares , Preparações Farmacêuticas/metabolismo , Receptores Acoplados a Proteínas G/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA